Simple Dosing - taken with or without food

  • BELVIQ XR: 20 mg - once daily;2
    BELVIQ: 10 mg - twice daily;1
    Oral dosing; small tablet*
  • * Bioequivalence was demonstrated between 20 mg, once-daily XR formulation and 10 mg, twice-daily dosing for BELVIQ2

  • Response to therapy should be evaluated at Week 12. If a patient has not lost at least 5% of baseline body weight, discontinue BELVIQ or BELVIQ XR, as it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment. If a patient has lost 5% weight loss of baseline body weight by Week 12, continuation of treatment may be considered among other factors
  1. BELVIQ [package insert]. Woodcliff Lake, NJ: Eisai Inc; 2016.
  2. BELVIQ XR [package insert]. Woodcliff Lake, NJ: Eisai Inc; 2016.

View Clinical Video Presentation

View Clinical Video Presentation

video overlay image